Instem's second-largest shareholder opposes deal with PE firm Archimed
28/09/2023 08:22
Sept 28 (Reuters) - Instem Plc's INS.L second-largest
shareholder, BGF, on said on Thursday it does not support French
private equity firm Archimed's 203 million pounds ($246.5
million) offer for the British life sciences software company.
BGF holds an 8.53% stake in Instem, making it the firm's
second-largest shareholder.
($1 = 0.8236 pounds)
(Reporting by Prerna Bedi in Bengaluru; Editing by Savio
D'Souza)
((Prerna.Bedi@thomsonreuters.com; +91 98052 24616;))